Growth Metrics

Bespoke Extracts (BSPK) EBITDA (2017 - 2025)

Bespoke Extracts' EBITDA history spans 9 years, with the latest figure at -$53891.0 for Q3 2025.

  • For Q3 2025, EBITDA rose 79.47% year-over-year to -$53891.0; the TTM value through Sep 2025 reached -$640301.0, up 40.74%, while the annual FY2024 figure was -$994628.0, 32.43% up from the prior year.
  • EBITDA for Q3 2025 was -$53891.0 at Bespoke Extracts, up from -$161958.0 in the prior quarter.
  • Across five years, EBITDA topped out at -$53891.0 in Q3 2025 and bottomed at -$1.1 million in Q3 2022.
  • The 5-year median for EBITDA is -$296192.0 (2023), against an average of -$409465.9.
  • The largest YoY upside for EBITDA was 90.67% in 2021 against a maximum downside of 83.75% in 2021.
  • A 5-year view of EBITDA shows it stood at -$67933.0 in 2021, then plummeted by 1226.57% to -$901176.0 in 2022, then skyrocketed by 70.6% to -$264914.0 in 2023, then surged by 32.39% to -$179114.0 in 2024, then surged by 69.91% to -$53891.0 in 2025.
  • Per Business Quant, the three most recent readings for BSPK's EBITDA are -$53891.0 (Q3 2025), -$161958.0 (Q2 2025), and -$245338.0 (Q1 2025).